PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 254 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,354,000 | -74.6% | 44,131 | -66.9% | 0.20% | -73.0% |
| Q2 2023 | $5,337,000 | +35.7% | 133,195 | +38.2% | 0.73% | +29.4% |
| Q1 2023 | $3,932,000 | +6.7% | 96,356 | +1.0% | 0.56% | +6.2% |
| Q4 2022 | $3,684,000 | -27.4% | 95,414 | -0.0% | 0.53% | -32.4% |
| Q3 2022 | $5,077,000 | -5.8% | 95,443 | +3.3% | 0.79% | -2.6% |
| Q2 2022 | $5,388,000 | -24.5% | 92,415 | -1.1% | 0.81% | -9.0% |
| Q1 2022 | $7,132,000 | – | 93,448 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |